Patient-reported outcomes from the phase III, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 Study of pembrolizumab plus concurrent chemoradiotherapy among patients with high-risk, locally advanced cervical cancer

Randall, Leslie; Sukhin, Vladyslav; Colombo, Nicoletta; Korach, Jacob; Matsumoto, Takashi; Lalondrelle, Susan; Vizkeleti, Julia; Samouelian, Vanessa; Salani, Ritu; Salman, Pamela et al

Más información

Año de Inicio/Término: Noviembre 2024
URL: https://doi.org/10.1016/j.ygyno.2024.07.020
DOI:

10.1016/j.ygyno.2024.07.020